Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 6, 2010, Pages 538.e1-538.e9

  Lowder, Jerry L ^a   Oliphant, Sallie S ^a   Ghetti, Chiara ^a   Burrows, Lara J ^a   Meyn, Leslie A ^a   Balk, Judith ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

prophylactic bilateral oophorectomy; removal of remaining ovary

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; OVARIECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREND STUDY; UNITED STATES; VAGINAL HYSTERECTOMY;

EID: 77952878109     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.11.030     Document Type: Article

References (41)

1. Whiteman M.K., Hillis S.D., Jamieson D.J., et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 198 (2008) 34.e1-34.e7
2. Keshavarz H., Hillis S.D., Kiele B.A., and Marchbanks P.A. Hysterectomy surveillance: United States, 1994-1999. MMWR Surveil Summ 51 (2002) 1-8. www.cdc.gov/MWR/preview/mmwrhtml/ss5105a1.htm Accessed April 1, 2009
3. American Cancer Society. Cancer facts & figures 2008. www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf Accessed April 1, 2009
4. Hankinson S.E., Hunter D.J., Colditz G.A., et al. Tubal ligation, hysterectomy, and risk of ovarian cancer: a prospective study. JAMA 270 (1993) 2813-2818
5. Utian W.H., and Goldfarb J. Ovarian management during radical hysterectomy in the premenopausal patient. Obstet Gynecol 82 (1993) 1042
6. Sightler S.E., Boike G.M., Estrape R.E., and Averette H.E. Ovarian cancer in women with prior hysterectomy: a 14-year experience at the University of Miami. Obstet Gynecol 78 (1991) 681-684
7. Counseller V.S., Hunt W., and Haigler F.H. Carcinoma of the ovary following hysterectomy. Am J Obstet Gynecol 69 (1955) 538-546
8. Parrazini F., Negri E., La Vecchia C., Luchini L., and Mezzopane R. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk. Obstet Gynecol 81 (1993) 63-66
9. Rocca W.A., Grossardt B.R., de Andrade M., Malkasian G.D., and Melton L.J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 7 (2006) 821-828
10. Parker W.H., Broder M.S., Chang E., et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health study. Obstet Gynecol 113 (2009) 1027-1037
11. Dennison C., and Pokras R. Design and operation of the National Hospital Discharge Survey: 1988 redesign. Vital Health Stat 1 (2000)
12. Jacoby V.L., Vittinghoff E., Nakagawa S., et al. Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions. Obstet Gynecol 113 (2009) 1259-1267
13. Parker W.H., Shoupe C., Broder M.S., Liu Z., Farquhar C., and Berek J.S. Elective oophorectomy in the gynecological patient: when is it desirable?. Curr Opin Obstet Gynecol 19 (2007) 350-354
14. Hendrix S.L. Bilateral oophorectomy and premature menopause. Am J Med 118 (2005) 131S-135S
15. Fogle R.H., Stanczyk F.Z., Zhang X., and Paulson R. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 92 (2007) 3040-3043
16. Wuest J., Dry T., and Edwards J. The degree of coronary atherosclerosis in bilaterally oophorectomized women. Circulation 7 (1953) 801-809
17. Kannel W.B., Hjortland M.C., McNamara P.M., and Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 85 (1976) 447-452
18. Beard C.M., Fuster V., and Annegers J.F. Reproductive history in women with coronary heart disease: the Framingham study. Am J Epidemiol 120 (1984) 108-114
19. Matthews K.A., Meilahnm E., Kuller L.H., et al. Menopause and risk factors of coronary heart disease. N Engl J Med 321 (1989) 641-646
20. Howard B.V., Kuller L., Langer R., et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Womens' Health Initiative observational study. Circulation 111 (2005) 1462-1470
21. Writing group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
22. Neron M. Deaths: leading causes for 2004. Natl Vital Stat Rep 56 (2007) 1-96
23. Cummings S., Browner W., Bauer D., et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med 339 (1998) 733-738
24. National Osteoporosis Foundation. Physician guide to prevention and treatment of osteoporosis (1998), Excerpta Medica, Inc, Beele Mead, NJ
25. Melton L.J., Khosla S., Malkasian G.D., Achenbach S.J., Oberg A.L., and Riggs B.L. Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res 18 (2003) 900-905
26. Parker W.H., Broder M.S., Liu Z., Shoupe D., Farquhar C., and Berek J.S. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 106 (2005) 219-226
27. Shoupe D., Parker W.H., Broder M.S., Liu Z., Farquhar C., and Berek J.S. Elective oophorectomy for benign gynecological disorders. Menopause 14 (2007) 580-585
28. Dekel A., Ewfrat Z., Orvieto R., et al. The residual ovary syndrome: a 20-year experience. Eur J Obstet Gynecol Reprod Biol 68 (1996) 159-164
29. Guay M.P., Dragomir A., Pilon D., Moride Y., and Perreault S. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Pharmacoepidemiol Drug Saf 16 (2007) 17-27
30. Lepine L.A., Hillis S.D., Marchbanks P.A., et al. Hysterectomy surveillance: United States, 1980-1993. MMWR CDC Surveill Summ 46 (1997) 1-15
31. Jacobson G.F., Shaber R.E., Armstrong M.A., and Hung Y.Y. Hysterectomy rates for benign conditions. Obstet Gynecol 107 (2006) 1278-1283
32. Farquhar C.M., and Steiner C.A. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 99 (2002) 229-234
33. Whiteman M.K., Hillis S.D., Jamieson D.J., et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 198 (2008) 34.e1-34.e7
34. Morrison Jr. J.E., and Jacobs V.R. Outpatient laparoscopic hysterectomy in a rural ambulatory surgery center. J Am Assoc Gynecol Laparosc 11 (2004) 359-364
35. Galen D.I., Jacobson A., and Weckstein L.N. Outpatient laparoscopic-assisted vaginal hysterectomy. J Am Assoc Gynecol Laparosc 1 (1994) 241-245
36. National Ambulatory Surgical Survey. www.cdc.gov/nchs/products/elec_prods/subject/nsas.html April 1, 2009
37. Owings M.F., and Kozak L.J. Ambulatory and inpatient procedures in the United States, 1996. Vital Health Stat 13 139 (1998) 1-119
38. Hurskainen R., Teperi J., Rissanen P., et al. Clinical outcomes and costs with the levonorgestrel releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 291 (2004) 1456-1463
39. Fraquhar C.M., Naoom S., and Steiner C.A. The impact of endometrial ablation on hysterectomy rates in women with benign uterine conditions in the United States. Int J Technol Assess Health Care 18 (2002) 625-634
40. The REST Investigators. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 356 (2007) 360-370
41. Ballard L.A., and Walters M.D. Transvaginal mobilization and removal of ovaries and fallopian tubes after vaginal hysterectomy. Obstet Gynecol 87 (1996) 35-39